Staying on Top of Medical Necessity and Marketer Compliance
Recent enforcement actions show that clinical laboratories must remain vigilant about compliance relating to these areas
Recent enforcement actions show that clinical laboratories must remain vigilant about compliance relating to these areas
From - Lab Compliance Advisor
After a recent dip, OIG enforcement activity has seemingly rebounded, at least in terms of total recoveries. That's the…
From - Lab Compliance Advisor
Fraudulent utilization and billing of urine drug screening first became a priority for federal enforcers since the…
From - Lab Compliance Advisor
Question: What happens when multiple whistleblowers bring separate qui tam lawsuits against a lab for the same offense…
From - Lab Compliance Advisor
It's not just new laws, regulations or even court cases. Trends in health care fraud enforcement are sometimes driven by changes in prosecution policies, including…
From - Lab Compliance Advisor
It wasn't the outcome the four hospital employees envisioned when they filed their lawsuit charging the…
From - Lab Compliance Advisor
Recent federal legislation addressing the opioid crisis may have unintended consequences on the lab industry. The idea was to allow the feds to prosecute a certain kind of…